Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.5500
-0.0100 (-1.79%)
At close: Apr 28, 2026
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $1.81 million as of April 28, 2026. Its market cap has decreased by -36.98% in one year.
Market Cap
1.81M
Enterprise Value
-1.04M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.55
Market Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 1.81M, a decrease of -93.43%. That is a compound annual growth rate of -26.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.84M | -14.80% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.21M |
| AXIM Biotechnologies | 2.03M |
| Protagenic Therapeutics | 1.76M |
| ZyVersa Therapeutics | 1.71M |
| Clearside Biomedical | 1.57M |
| Agentix | 1.52M |
| inTerra Resources | 1.47M |